Prospects and challenges in using neuronal extracellular vesicles in biomarker research
Open Access
- 15 July 2024
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (9) , 6632-6638
Abstract
Extracellular vesicles (EVs) hold promise as a source of disease biomarkers. The diverse molecular cargo of EVs can potentially indicate the status of their tissue of origin, even against the complex background of whole plasma. The main tools currently available for assessing biomarkers of brain health include brain imaging and analysis of the cerebrospinal fluid of patients. Given the costs and difficulties associated with these methods, isolation of EVs of neuronal origin (NEVs) from the blood is an attractive approach to identify brain‐specific biomarkers. This perspective describes current key challenges in EV‐ and NEV‐based biomarker research. These include the relative low abundance of EVs, the lack of validated isolation methods, and the difficult search for an adequate target for immunocapturing NEVs. We discuss that these challenges must be addressed before NEVs can fulfill their potential for biomarker research.Highlights: NEVs are promising sources of biomarkers for brain disorders. Immunocapturing NEVs from complex biofluids presents several challenges. The choice of surface target for capture will determine NEV yield. Contamination by non‐EV sources is relevant for biomarkers at low concentrations.Keywords
This publication has 53 references indexed in Scilit:
- Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approachesJournal of Extracellular Vesicles, 2024
- Alzheimer's disease brain‐derived extracellular vesicles reveal altered synapse‐related proteome and induce cognitive impairment in miceAlzheimer's & Dementia, 2023
- Validation of α‐Synuclein in L1CAM‐Immunocaptured Exosomes as a Biomarker for the Stratification of Parkinsonian SyndromesMovement Disorders, 2021
- Recent insights into the role of L1CAM in cancer initiation and progressionInternational Journal of Cancer, 2020
- Biomarker potential of brain‐secreted extracellular vesicles in blood in Alzheimer's diseaseAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2020
- Association of Extracellular Vesicle Biomarkers With Alzheimer Disease in the Baltimore Longitudinal Study of AgingJAMA Neurology, 2019
- What is the blood concentration of extracellular vesicles? Implications for the use of extracellular vesicles as blood-borne biomarkers of cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2019
- Exosomal biomarkers of brain insulin resistance associated with regional atrophy in Alzheimer's diseaseHuman Brain Mapping, 2017
- The ubiquitous neural cell adhesion molecule (N-CAM)Annals of Medicine & Surgery, 2014
- Molecular markers of sympathoadrenal cellsCell and tissue research, 1999